Northeast Pharmaceutical Group Co Ltd (000597) — Cash Flow Reinvestment Rate
Northeast Pharmaceutical Group Co Ltd (000597) has a Cash Flow Reinvestment Rate of 0.04x as of September 2025, reinvesting CN¥11.48 Million (capex CN¥11.48 Million ) from operating cash flow of CN¥274.09 Million. Explore 000597 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Northeast Pharmaceutical Group Co Ltd Cash Flow Reinvestment Rate (1999–2025)
Historical reinvestment intensity for Northeast Pharmaceutical Group Co Ltd across 23 annual periods. Also explore 000597 asset base for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Northeast Pharmaceutical Group Co Ltd (1999–2025)
Year-by-year capital reinvestment analysis for Northeast Pharmaceutical Group Co Ltd. For live market cap and broader valuation context, see 000597 market cap overview.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.09x | CN¥100.65 Million | CN¥1.11 Billion | CN¥97.78 Million | ▼ -84.4% |
| 2024 | 0.58x | CN¥443.39 Million | CN¥758.76 Million | CN¥159.43 Million | ▼ -26.0% |
| 2023 | 0.79x | CN¥463.40 Million | CN¥586.75 Million | CN¥235.43 Million | ▲ +74.9% |
| 2022 | 0.45x | CN¥500.47 Million | CN¥1.11 Billion | CN¥244.13 Million | ▲ +148.3% |
| 2021 | 0.18x | CN¥135.71 Million | CN¥746.51 Million | CN¥119.81 Million | ▼ -75.1% |
| 2020 | 0.73x | CN¥416.28 Million | CN¥570.92 Million | CN¥400.38 Million | ▲ +4.9% |
| 2019 | 0.70x | CN¥245.06 Million | CN¥352.60 Million | CN¥229.17 Million | ▼ -65.9% |
| 2018 | 2.04x | CN¥581.64 Million | CN¥285.09 Million | CN¥565.74 Million | ▲ +10.2% |
| 2016 | 1.85x | CN¥712.04 Million | CN¥384.51 Million | CN¥177.01 Million | ▼ -74.2% |
| 2015 | 7.18x | CN¥716.04 Million | CN¥99.70 Million | CN¥346.04 Million | ▼ -36.6% |
| 2014 | 11.33x | CN¥532.27 Million | CN¥46.99 Million | CN¥532.27 Million | ▲ +445.1% |
| 2012 | 2.08x | CN¥178.90 Million | CN¥86.09 Million | CN¥178.90 Million | ▲ +12.2% |
| 2010 | 1.85x | CN¥473.93 Million | CN¥255.96 Million | CN¥473.93 Million | ▲ +32.2% |
| 2009 | 1.40x | CN¥862.78 Million | CN¥615.91 Million | CN¥862.78 Million | ▲ +176.5% |
| 2008 | 0.51x | CN¥359.27 Million | CN¥709.03 Million | CN¥359.27 Million | ▲ +14.6% |
| 2007 | 0.44x | CN¥87.78 Million | CN¥198.56 Million | CN¥87.78 Million | ▼ -52.5% |
| 2005 | 0.93x | CN¥103.66 Million | CN¥111.40 Million | CN¥103.66 Million | ▲ +221.2% |
| 2004 | 0.29x | CN¥61.14 Million | CN¥211.06 Million | CN¥61.14 Million | ▼ -23.8% |
| 2003 | 0.38x | CN¥87.46 Million | CN¥230.08 Million | CN¥87.46 Million | ▲ +57.1% |
| 2002 | 0.24x | CN¥38.07 Million | CN¥157.41 Million | CN¥38.07 Million | ▼ -59.1% |
| 2001 | 0.59x | CN¥46.57 Million | CN¥78.84 Million | CN¥46.57 Million | ▲ +75.2% |
| 2000 | 0.34x | CN¥12.18 Million | CN¥36.13 Million | CN¥12.18 Million | ▲ +95.9% |
| 1999 | 0.17x | CN¥9.41 Million | CN¥54.62 Million | CN¥9.41 Million | — |